Thursday, May 27, 2021

SYNGENE | Stock Analysis And Price Outlook


Syngene International Ltd.

Stock Price: 595

➽ Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India and internationally. The company offers discovery chemistry services.

Nature ➽  Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators

INDOSTAR | Stock Analysis And Price Outlook   

Key  Summary

Promoters have decreased holdings from 70.59% to 70.58% in Mar 2021 qtr

Mutual Funds have decreased holdings from 4.67% to 3.94% in Mar 2021 qtr

Number of MF schemes decreased from 21 to 18 in Mar 2021 qtr

FII/FPI have decreased holdings from 14.29% to 14.25% in Mar 2021 qtr

Number of FII/FPI investors decreased from 241 to 220 in Mar 2021 qtr

Institutional Investors have decreased holdings from 20.11% to 19.51% in Mar 2021 qtr

Financial Data Highlights

Market Cap23298.61
Book Value/ Share70.974
Enterprise Value6790.16
Revenue TTM2184.30
Gross Profit TTM1657.80
Revenue /Share TTM54.92

Technical Chart & Price Outlook

Strong Momentum: Price above short, medium and long term moving averages.
Hold and accumulate for 638 in short term and 713 in mid term time frame.

Recent Valuation Summary

Growth in Net Profit with increasing Profit Margin (QoQ)

Company with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Increasing profits every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company with Zero Promoter Pledge

Near 52 Week High   

Key Profit & Loss Data

Net Inc404.901.75 %
Ops Income380.201.04 %
Revenue2184.308.57 %
Ops Expense1804.1020.64 %
PBT469.209.23 %
Gross Profit1657.8014.59 %
Div Paid0100.00 %

Thanks for your Precious Time.

Finvest Online
Telegram  :

r- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader,user and company that are mention on this website.We are not SEBI registered financial advisor or analyst.

No comments:

Post a Comment